Abstract

Infections of the pulmonary system, being the most common pathologies in humans, can cause serious complications. In this regard, it is essential to select etiopathogen and to provide adequate treatment of different clinical forms of respiratory infections, to solve the issue of necessary, the appointment of antibacterial therapy, to choose the drugs most active against the alleged causal germs. In recent years, there has been an increasing amount of evidence that has led to a review of traditional views on the etiology and regimens of antibacterial chemotherapy for respiratory infections.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call